Covid vaccine for children: FDA approves pfizer’s low-dose jab for kids aged 5 to 11
In a big relief to millions of parents, the Food and Drug Administration (FDA) on Saturday approved the Pfizer Covid vaccine for children aged 5 to 11, making it the first shot against the deadly virus for kids in the United States. The development comes two days after an FDA advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks.
However, the shot will not be immediately available to the age group as on Tuesday advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterward.
How Experts Reacted?
“The rationale here is to protect your children so that they can get back towards normal life,” said FDA vaccine chief Dr. Peter Marks. “The tremendous cost of this pandemic has not just been in physical illness, it’s been in the psychological, the social development of children” too.
The American Academy of Pediatrics also applauded FDA’s decision and said pediatricians were “standing by” to talk with parents.
Vaccinating this age group is “an important step in keeping them healthy and providing their families with peace of mind,” said Dr. Lee Savio Beers, the academy’s president.
Echoing similar remarks, Dr. Kawsar Talaat of Johns Hopkins University asserted,”With this vaccine kids can go back to something that’s better than being locked at home on remote schooling, not being able to see their friends. The vaccine will protect them and also protect our communities.”